Clinical trial
Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue for Targeting of Colon Cancer
NCT03774680 is registered in ClinicalTrials.gov with Ahmed A. H. Abdellatif as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue for Targeting of Colon Cancer
- Lead sponsor
- Ahmed A. H. Abdellatif
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- February 1, 2020
- Completion date
- January 11, 2021
- Enrollment
- 30 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
colo-rectal cancer, colon cancer